Clinical Trial Update: Study To Determine The Effects And Safety Of A Weight Loss Compound On Overweight, Otherwise Healthy, Volunteers [Phase 2]

View source ↗

Summary

Phase 2 trial completed to evaluate the effects and safety of a weight loss compound in overweight but otherwise healthy volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Weight loss compound (Pfizer)

Snippet

Sponsor: Pfizer | Conditions: Obesity | Phase 2 | Status: COMPLETED